Caxton Associates (New York)’s Allogene Therapeutics ALLO Stock Holding History

Caxton Associates (New York)’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$440K	Sell
2024 Q3	$678K	Sell
2024 Q2	$1.09M	Buy
2024 Q1	$1.93M	Sell
2023 Q4	$2.49M	Buy
2023 Q3	$1.52M	Buy
2023 Q2	$346K	Buy
2023 Q1	$108K	Buy
2022 Q2	–	Sell
2022 Q1	$379K	Buy